Order Article Reprints

Casadei B, Argnani L, Broccoli A, Patti C, Stefani PM, Cuneo A, Margiotta Casaluci G, Visco C, Gini G, Pane F, et al. Treatment with Idelalisib in Patients with Relapsed or Refractory Follicular Lymphoma: The Observational Italian Multicenter FolIdela Study. Cancers. 2022; 14(3):654. https://doi.org/10.3390/cancers14030654

Casadei, Beatrice, Lisa Argnani, Alessandro Broccoli, Caterina Patti, Piero Maria Stefani, Antonio Cuneo, Gloria Margiotta Casaluci, Carlo Visco, Guido Gini, Fabrizio Pane, and et al. 2022. "Treatment with Idelalisib in Patients with Relapsed or Refractory Follicular Lymphoma: The Observational Italian Multicenter FolIdela Study" Cancers 14, no. 3: 654. https://doi.org/10.3390/cancers14030654

Casadei, B., Argnani, L., Broccoli, A., Patti, C., Stefani, P. M., Cuneo, A., Margiotta Casaluci, G., Visco, C., Gini, G., Pane, F., D’Alò, F., Luzi, D., Cantonetti, M., Pozzi, S., Musuraca, G., Rosignoli, C., Arcari, A., Kovalchuk, S., Tani, M., ... Zinzani, P. L. (2022). Treatment with Idelalisib in Patients with Relapsed or Refractory Follicular Lymphoma: The Observational Italian Multicenter FolIdela Study. Cancers, 14(3), 654. https://doi.org/10.3390/cancers14030654